Regulatory authorities and orthopaedic clinical trials on expanded mesenchymal stem cells

The relative incidence of fracture non-union in the Scottish population (5.17 million): a 5-year epidemiological study

(2013) Leanora Anne Mills et al.   BMJ Open

Osteoporotic hip fractures: Bisphosphonates sales and observed turning point in trend. A population-based retrospective study

(2012) Sandra Maria Alves et al.   BONE

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010

(2012) Joshua A Salomon et al.   LANCET

Clinical Development of Advanced Therapy Medicinal Products in Europe: Evidence That Regulators Must Be Proactive

(2012) Romaldas Maciulaitis et al.   MOLECULAR THERAPY

Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology

(2011) Enrique Gómez-Barrena et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Perivascular Multipotent Progenitor Cells in Human Organs

(2009) Mihaela Crisan et al.   Annals of the New York Academy of Sciences

Aging Adversely Impacts Biological Properties of Human Bone Marrow-derived Mesenchymal Stem Cells: Implications for Tissue Engineering Heart Valve Construction

(2009) Yuan Xin et al.   ARTIFICIAL ORGANS

Research ethics committees in Europe: trials and tribulations

(2009) Christiane Druml et al.   INTENSIVE CARE MEDICINE

The Global Burden of Musculoskeletal Injuries: Challenges and Solutions

(2008) Charles Mock et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH